The Adult Hematology Clinic in the Division of Hematology at Brigham and Women’s Hospital is part of the multidisciplinary Dana-Farber Brigham Cancer Center. One of the largest centers for adults with blood and bone marrow diseases, the clinic welcomes patients internationally for diagnosis and treatment.
Since the clinical manifestations and the personal impact of the diseases we treat vary widely, our collaborative team of hematologists, pathologists, radiation oncologists, social workers and nurse practitioners develop individualized treatment plans that target disease while addressing unique patient needs. The treatment team also includes specialists in blood transfusion and nuclear medicine.
The Adult Hematology Clinic provides treatment for patients with a wide array of conditions, including:
In these conditions, the supply of red blood cells or hemoglobin (which carries oxygen to bodily tissues) declines. They include iron deficiency anemia, anemia of chronic disease, vitamin B12 deficiency, sickle cell anemia, and thalassemia.
Conditions in which the blood fails to clot properly or where patients have an increased tendency to form clots. Types include hemophilia, von Willebrand’s disease and inherited and acquired thrombophilia, including antiphospholipid syndrome.
Conditions involving white blood cells, agents of the immune system that fight disease, including neutropenia and leukocytosis.
Conditions involving blood platelets needed for clotting, such as thrombocytopenia (ITP and TTP) and thrombocytosis.
Disorders of the bone marrow in which too many blood cells are produced. Types include: polycythemia vera, thrombocythemia, chronic myelogenous leukemia, and primary myelofibrosis.
Conditions of the bone marrow in which not enough blood cells are produced, such as aplastic anemia, such as aplastic anemia, other congenital and acquired bone marrow failure syndromes, including myelodysplasia and paroxysmal nocturnal hemoglobinuria.
Conditions in which the body fails to process iron properly, such as hemochromatosis and porphyria.
These conditions involve certain immune system cells and disease-fighting proteins. They include benign monoclonal gammopathy, cryoglobulinemia, and amyloidosis.
The Clinic also helps patients manage the taking of anticoagulant medications such as warfarin, low molecular weight heparin, direct oral anticoagulations and anti-platelet agents.
Clinical Director, Non-Malignant Hematology Clinic
Associate Chief of Hematology for Research
Chief of Hematology
Chief of Medicine, Brigham and Women's Faulkner Hospital
Medical Director, Anticoagulation Management Service, BWH and Dana-Farber Cancer Institute
For over a century, a leader in patient care, medical education and research, with expertise in virtually every specialty of medicine and surgery.